SSX2 抗体
(Synovial Sarcoma, X Breakpoint 2 (SSX2))
The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X\\\\;18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].
Recommended next Filters:
47 results
Latest Publications for our SSX2 抗体
: "SSX2-4 expression in early-stage non-small cell lung cancer." in: Tissue antigens, Vol. 83, Issue 5, pp. 344-9, (2014) (PubMed).: "Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer." in: Cancer research, Vol. 71, Issue 21, pp. 6785-95, (2011) (PubMed).
: "Yeast-based identification of prostate tumor antigens provides an effective vaccine platform." in: Anticancer research, Vol. 30, Issue 3, pp. 895-902, (2010) (PubMed).
Aliases for SSX2 抗体
SSX family member 2 (SSX2) 抗体protein SSX2 (LOC741661) 抗体
synovial sarcoma, X breakpoint 2 (Ssx2) 抗体
CT5.2 抗体
CT5.2A 抗体
HD21 抗体
HOM-MEL-40 抗体
SSX 抗体
SSX2 抗体
SSX3 抗体
您还需要查找其他产品吗？
You are here:
